CIK: 0001821219 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 17, 2021
Total Value ($000): $132,408 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JPM | JPMORGAN CHASE | 245,000 | $38,107 | 28.8% | $81.74 | +70.9% | COMMON EQUITY | 46625H100 |
| BRK/A | BERKSHIRE HATHAWAY INC CL A | 33 | $13,813 | 10.4% | $313571.66 | +34.0% | COMMON EQUITY | 084670108 |
| BABA | ALIBABA GROUP HOLDING-SP ADR | 50,000 | $11,339 | 8.6% | $226.78 | — | COMMON EQUITY | 01609W102 |
| WAL | WESTERN ALLIANCE BANCORP | 120,000 | $11,142 | 8.4% | $30.98 | +188.8% | COMMON EQUITY | 957638109 |
| KKR | KKR | 100,000 | $5,924 | 4.5% | $25.46 | +109.5% | COMMON EQUITY | 48251W104 |
| ACGL | ARCH CAPITAL GROUP LTD | 150,000 | $5,841 | 4.4% | $31.21 | +20.6% | COMMON EQUITY | G0450A105 |
| GS | GOLDMAN SACHS GROUP INC | 15,000 | $5,692 | 4.3% | $164.18 | +94.6% | COMMON EQUITY | 38141G104 |
| OZK | BANK OZK | 125,000 | $5,270 | 4.0% | $17.43 | +102.5% | COMMON EQUITY | 06417N103 |
| — | CADENCE BANCORP | 250,000 | $5,220 | 3.9% | $8.86 | — | COMMON EQUITY | 12739A100 |
| ACN | ACCENTURE PLC CL A | 15,000 | $4,421 | 3.3% | $174.62 | +53.6% | COMMON EQUITY | G1151C101 |
| PGR | PROGRESSIVE CORP | 45,000 | $4,419 | 3.3% | $66.35 | +33.4% | COMMON EQUITY | 743315103 |
| — | AMRYT PHARMA LTD - SPNR ADR | 315,000 | $3,821 | 2.9% | $12.22 | — | COMMON EQUITY | 03217L106 |
| SCHW | SCHWAB (CHARLES) CORP | 50,000 | $3,641 | 2.7% | $33.18 | +100.7% | COMMON EQUITY | 808513105 |
| AON | AON PLC CLASS A | 15,000 | $3,581 | 2.7% | $178.56 | +32.3% | COMMON EQUITY | G0403H108 |
| C | CITIGROUP INC | 50,000 | $3,538 | 2.7% | $38.68 | +62.1% | COMMON EQUITY | 172967424 |
| NTRS | NORTHERN TRUST CORP | 30,000 | $3,469 | 2.6% | $66.60 | +49.1% | COMMON EQUITY | 665859104 |
| WFC | WELLS FARGO | 70,000 | $3,170 | 2.4% | $23.98 | +66.7% | COMMON EQUITY | 949746101 |